Phase 1 investigator-initiated study of Plinabulin + PD-1/PD-L1 inhibitor + radiation (MD Anderson Cancer Center) showed ...

Avammune Therapeutics is a biopharmaceutical company discovering small molecule medicines that target the innate immune ...

Avammune Therapeutics has raised $12 Mn as a part of its Series A funding round co-led by Capital 2B, Shastra VC and Kotak ...

Founded in 2020 by Arun B Papaiah, Srinivasan Namala, and Aditya Kulkarni, Avammune focuses on developing small molecule ...

Avammune Therapeutics secured $12 million in Series A funding to advance its small molecule immunotherapies targeting cancer ...

In this digital age, receiving fewer personal letters than ever via post, we value them even more. Someone has given time and ...